Should we be targeting type 1 interferons in antiphospholipid syndrome?
Copyright © 2023. Published by Elsevier Inc.
Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 255(2023) vom: 15. Okt., Seite 109754 |
---|---|
Auteur principal: | |
Autres auteurs: | , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2023
|
Accès à la collection: | Clinical immunology (Orlando, Fla.) |
Sujets: | Review Journal Article Research Support, Non-U.S. Gov't Antiphospholipid syndrome Autoimmunity IFN-1 antagonists Plasmacytoid dendritic cells Type-1 interferons Interferon Type I Interferons |
Accès en ligne |
Volltext |